Notably, statins, which are drugs that decrease cholesterol synthesis in the liver via the inhibition of HMG-CoA reductase, have been associated with lower cancer-related mortality in patients with various types of cancer, including CRC [12,13]. This evidence concerns the gene HMGCR and cancer.